I watched both ACAD and SGEN closely this past week. As a holder of both, I'm really happy with ACAD's move, and yes it was on decent volume. But the buying of SGEN was an entirely different story, in terms of volume. As I noted on another post, there was one day where we had the average daily volume traded in the last half hour alone. One other day was nearly as impressive, and the remaining days were strong, too.
I have no idea what's going on, but I'm hoping it goes beyond just a sector rebound.
Bios are biggest growth engine for big pharma. Only a matter of time. IMO. Good luck bio investors. Patience will be rewarded.
Not to worry. Madame Yellen or crooked Hellery will soon make a statement to fix that biotech rally.
Seriously though, I'd give it another couple of days to makesure but looks really good if it holds.
No form 4. Looks like Bakers are not the cause of price surge and up volume. with similar action in acad and others, maybe tide has turned in biotechs. Especially SGEN and other baker holdings! Hopefully optimistic.
ACAD is Nupi today, but could be much more!! tbc--both are great companies...and as I am sure you know both BB holdings...dont think ya can go wrong either way...
With sgen, always held a large core, about 2/3 of my maximum sgen holdings. The other one third I traded in and out as it rotated up and down within a given channel. Did a lot of that in the early years when you could quickly pick up a couple of dollars on a lower PPS on 10k or 20k shares in a week. Haven't done it in recent couple of years as its no longer worth it from my perspective. Now just holding for the Big Bang - it's all house money at this point.
With acad, haven't traded it as it was not as predictable, again from my perspective. Sold some of my original core. The rest holding again for the Big Bang.
Overall, stayed substantially in both because I 've felt they offered the best risk/reward at any given point in time. I'm not a fan of taking profits just because of a good run. To me, it's always what the best investment choice for today and tomorrow, not what happened yesterday.
Impressive that you have stayed in both given their respective runs. I am curious, have you traded in and out, added on the way up, or just established a position early and let it run? Just curious how you handled that. Thanks.
Well, I also agree (not with the Trump part) and I'm on record as opining that the Bakers are where they want to be in SGEN and are just sitting back now and waiting for the right bid at the right price at the right time. Guess we'll see tonight - if no Form 4 from them by tonight - it probably wasn't them.
Hopefully they won't. SGEN has been range bound for two years and a breakout should be imminent. If The price spike is once again due to BB buying then it will sink back to low 30's. Surely it is circumstantial but it has been clockwork that as soon as the biotech index has an couple of good days the Fed crash the market. I'm almost impatient for the day that president Trump fires the ugly windbag.
Nice going. I love it when these bio stocks tank and you can buy below the Baker's. It's usually a safe bet if you know when to sell. You are safe with your ACAD since you bought so cheap. Good Luck on that one too. I'm tempted to buy GILD again. Might see if it goes lower next week.
If you like the stocks Baker's are buying and want to pay less than their purchase check out AQXP. JNJ and PFE both sold their shares at a much higher price while the Baker's have been adding. Look at insider trades and buy for 1/2 the price. Get out with profits or ???.
CERS has captured 80% United States market share over the the last 120 days, with back-ended 2016 Revenue, with 2017, 2018 exponential Revenue growth (recently per the CEO). Cerus is preparing to launch their Intercept triple dose-set product in Europe, which is a $2 billion dollar Revenue potential opportunity...
Sentiment: Strong Buy